Cara Therapeutics was incorporated in the state of Delaware in July 2004.
The Company’s headquarters are located at 4 Stamford Plaza, 107 Elm Street, 9th Floor, Stamford, CT 06902. The main office phone number is (203) 406-3700.
Cara’s stock is traded on the NASDAQ Global Market under the symbol CARA. Their initial public offering (IPO) was on January 30, 2014.
The underwriters were Stifel, Piper Jaffray, Canaccord Genuity, Needham & Company, and Janney Montgomery Scott.
The CUSIP number for the Company’s common stock is 140755 109.
Cara does not currently have a direct stock purchase plan.
Cara does not currently offer a dividend reinvestment program, and does not expect to declare or pay dividends on our common stock in the foreseeable future.
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
If you have misplaced your stock certificates, please contact Cara’s transfer agent, American Stock Transfer & Trust Company, LLC. There may be a fee involved for replacing lost stock certificates.
The Company’s fiscal year ends on December 31.
Our legal counsel is:
1114 Avenue of the Americas
New York, New York 10036
+1 (212) 479-6000
Our independent auditor is:
Ernst & Young LLP
300 First Stamford Place
Stamford, CT 06902
Our next annual shareholder meeting will be held on June 3, 2021.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financials & Filings section of our Investor Relations webpage or directly from the SEC at www.sec.gov.